DCTH · Delcath Systems, Inc.

$11.69 +0.14 (+1.17%)

Market Cap

$398.73M

34.52M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$635,707	—	—	$4,774,551	$355,000	—	$5,765,258
Vojislav Vukovic	Chief Medical Officer	$488,000	—	—	$1,383,395	$184,000	—	$2,055,395
Martha Rook	COO	$460,833	—	—	$1,383,395	$180,000	—	$2,024,228

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$560,622	—	—	$1,230,036	$366,756	—	$2,157,414
Vojislav Vukovic	Chief Medical Officer	$465,000	—	—	$410,012	$210,600	—	$1,085,612
Martha Rook	COO	$336,458	—	—	$445,625	$151,014	—	$933,097

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$538,078	—	—	$1,792,348	$189,888	—	$2,520,314
John Purpura	COO	$409,229	—	—	$663,821	$129,977	—	$1,203,027
Kevin Muir	Vice President of Commercial Operations	$316,272	—	—	$621,582	$78,130	—	$1,015,984
Martha Rook	COO	—	—	—	—	—	—	—
Vojislav Vukovic	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$521,024	—	—	$800,499	$131,175	$19,500	$1,472,198
John Purpura	COO	$396,136	—	—	$318,407	$89,785	—	$804,328
Johnny John	Senior Vice President of Medical Affairs and Clinical Development	$393,023	$79,140	—	$265,341	—	—	$737,504
General Manager	Interventional Oncology	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$475,151	$130,666	—	$1,230,585	—	$78,000	$1,914,402
John Purpura	COO	$386,823	$95,739	—	$442,927	—	—	$925,489
Johnny John	Senior Vice President of Medical Affairs and Clinical Development	$325,557	$58,078	—	$492,142	—	—	$875,777

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gerard Michel	CEO	$112,500	—	—	$5,629,000	—	$19,500	$5,761,000
John Purpura	COO	$347,500	$57,870	—	$1,981,900	—	$32,000	$2,419,270
Johnny John	Senior Vice President of Medical Affairs and Clinical Development	$256,632	$23,740	—	$849,395	—	—	$1,129,767
Christine Padula	Principal Accounting Officer	$160,800	$15,000	—	$226,500	—	$24,500	$426,770
Jennifer K. Simpson	CEO	$253,322	—	—	—	—	—	$253,322

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jennifer K. Simpson	CEO	$466,594	$508,495	—	$90,706	—	—	$1,065,795
Barbra Keck	CFO	$324,000	$311,449	—	$64,790	—	—	$700,239
John Purpura	COO	$335,000	$288,151	—	$59,390	—	—	$682,541
Gerard Michel	CEO	—	—	—	—	—	—	—
Christine Padula	Principal Accounting Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jennifer K. Simpson	CEO	$466,594	$75,000	—	—	—	—	$541,594
John Purpura	COO	$335,000	$50,000	—	—	—	—	$385,000
Barbra Keck	CFO	$324,000	$50,000	—	—	—	—	$374,000

Key facts CIK 872912 CUSIP 24661P807 13F (30d) 20 filings 20 filers Visit website Investor relations